{
    "title": "Pfizer CEO says Omicron-targeted vaccine is most likely outcome",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10388327/Pfizer-CEO-says-Omicron-targeted-vaccine-likely-outcome.html",
    "date": "2022-01-10",
    "keywords": [
        "vaccine",
        "covid19",
        "bourla",
        "pfizer",
        "shot",
        "technology",
        "variant",
        "company",
        "march",
        "inc",
        "use",
        "development",
        "jan",
        "executive",
        "albert",
        "monday",
        "omicron",
        "coronavirus",
        "partner",
        "biontech",
        "se",
        "version",
        "scenario",
        "speaking",
        "jp",
        "healthcare",
        "conference",
        "year",
        "lot",
        "approval",
        "launch",
        "manufacturing",
        "capacity",
        "problem",
        "highrisk",
        "ceo",
        "stephane",
        "bancel",
        "week",
        "fall",
        "efficacy",
        "spike",
        "booster",
        "dose",
        "repeat",
        "vaccination",
        "sell",
        "httpswwwreuterscombusinesshealthcarepharmaceuticalspandemicfatiguemakescaseboostershardersell20220110",
        "day",
        "messenger",
        "rna",
        "pact",
        "worth",
        "beam",
        "drugmaker",
        "codex",
        "dna",
        "biotechs",
        "biopharma",
        "deal",
        "biotech",
        "companys",
        "nanoparticle",
        "erman",
        "york",
        "bhanvi",
        "satija",
        "manojna",
        "maddipatla",
        "roy",
        "bengaluru",
        "editing",
        "syamnath",
        "aditya",
        "soni"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}